$STSS DD for any new eyes: -Recent IPO at 4.25 -Low-float of 5.4m -Insider buys ranging from 1.20 to 4.25 -Patented and FDA approved product -Low dead space syringes = more doses per vial of medication -Needlestick prevention -Can only be used once -FDA approved and CE marked manufacturing facility -Net tangible value post-IPO dilution is at least 2x current SP -Former CEO and current chairman served as president (head of vaccines) for Merck for nearly 30 years -Recently acquired Safeguard Medical -Several potential catalysts expected in the coming months Not very many eyes on this, could 3x easily with volume. More info in comments. Verify on your own and add to the watchlist!
6
2